This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations of Bryan Ks Yeung
Introduction
Bryan Ks Yeung is an accomplished inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address viral infections. His innovative work has led to the creation of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Bryan Ks Yeung holds a patent for N-substituted tetrahydrothienopyridine derivatives and their uses. This compound, represented by Formula (I), has demonstrated efficacy in treating diseases caused by viral infections. The specific structural components, including R, A, L, m, n, p, and q, are defined within the patent documentation, highlighting the complexity and potential of this invention.
Career Highlights
Currently, Bryan is associated with Novartis AG, a leading global healthcare company. His role at Novartis allows him to collaborate with other experts in the field and contribute to groundbreaking research and development initiatives. His work is characterized by a commitment to innovation and a focus on improving patient outcomes through effective treatments.
Collaborations
Bryan has had the opportunity to work alongside talented colleagues, including Cyrille Kounde and Wei Lin Sandra Sim. These collaborations have enriched his research experience and fostered a dynamic environment for innovation.
Conclusion
Bryan Ks Yeung's contributions to the field of pharmaceuticals through his patent and work at Novartis AG exemplify the impact of dedicated inventors in advancing medical science. His innovative spirit continues to inspire progress in the treatment of viral infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
